Terns Pharmaceuticals, Inc. - Common Stock (TERN)
CUSIP: 880881107
Q2 2021 13F Holders as of 30 Jun 2021
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 105,357,143
- Total 13F shares
- 16,621,217
- Share change
- -1,283,987
- Total reported value
- $203,777,000
- Price per share
- $12.26
- Number of holders
- 36
- Value change
- -$24,794,385
- Number of buys
- 17
- Number of sells
- 22
Quarterly Holders Quick Answers
What is CUSIP 880881107?
CUSIP 880881107 identifies TERN - Terns Pharmaceuticals, Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 880881107:
Top shareholders of TERN - Terns Pharmaceuticals, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC |
13F
|
Company |
3.6%
|
3,791,204
|
$83,406,000 | — | 31 Mar 2021 | |
| FMR LLC |
13F
|
Company |
2.7%
|
2,887,738
|
$63,530,000 | — | 31 Mar 2021 | |
| Vivo Capital, LLC |
13F
|
Company |
2.5%
|
2,675,133
|
$58,853,000 | — | 31 Mar 2021 | |
| DEERFIELD MANAGEMENT COMPANY, L.P. |
13F
|
Company |
2.2%
|
2,345,959
|
$51,611,000 | — | 31 Mar 2021 | |
| SUVRETTA CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.1%
|
1,125,136
|
$24,753,000 | — | 31 Mar 2021 | |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC |
13F
|
Company |
1%
|
1,071,421
|
$23,571,000 | — | 31 Mar 2021 | |
| Antara Capital LP |
13F
|
Company |
0.71%
|
751,813
|
$16,275,000 | — | 31 Mar 2021 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.55%
|
575,793
|
$12,668,000 | — | 31 Mar 2021 | |
| Samsara BioCapital, LLC |
13F
|
Company |
0.47%
|
497,555
|
$10,946,000 | — | 31 Mar 2021 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.39%
|
407,349
|
$8,962,000 | — | 31 Mar 2021 | |
| Avidity Partners Management LP |
13F
|
Company |
0.38%
|
400,000
|
$8,800,000 | — | 31 Mar 2021 | |
| CAAS CAPITAL MANAGEMENT LP |
13F
|
Company |
0.33%
|
350,000
|
$7,700,000 | — | 31 Mar 2021 | |
| PFM Health Sciences, LP |
13F
|
Company |
0.31%
|
329,274
|
$7,244,000 | — | 31 Mar 2021 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.12%
|
130,263
|
$2,865,000 | — | 31 Mar 2021 | |
| STATE STREET CORP |
13F
|
Company |
0.09%
|
98,647
|
$2,170,000 | — | 31 Mar 2021 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.09%
|
91,787
|
$2,019,000 | — | 31 Mar 2021 | |
| SPHERA FUNDS MANAGEMENT LTD. |
13F
|
Company |
0.07%
|
70,000
|
$1,540,000 | — | 31 Mar 2021 | |
| Marshall Wace North America L.P. |
13F
|
Company |
0.04%
|
41,792
|
$919,000 | — | 31 Mar 2021 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.03%
|
32,621
|
$718,000 | — | 31 Mar 2021 | |
| COWEN AND COMPANY, LLC |
13F
|
Company |
0.02%
|
25,000
|
$550,000 | — | 31 Mar 2021 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.02%
|
23,536
|
$518,000 | — | 31 Mar 2021 | |
| NORGES BANK |
13F
|
Company |
0.02%
|
23,068
|
$507,000 | — | 31 Mar 2021 | |
| Zimmer Partners, LP |
13F
|
Company |
0.02%
|
22,500
|
$495,000 | — | 31 Mar 2021 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.02%
|
21,359
|
$470,000 | — | 31 Mar 2021 | |
| Pinz Capital Management, LP |
13F
|
Company |
0.02%
|
19,948
|
$439,000 | — | 31 Mar 2021 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.02%
|
19,279
|
$424,000 | — | 31 Mar 2021 | |
| Laurion Capital Management LP |
13F
|
Company |
0.01%
|
15,000
|
$330,000 | — | 31 Mar 2021 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.01%
|
14,085
|
$310,000 | — | 31 Mar 2021 | |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM |
13F
|
Company |
0.01%
|
13,135
|
$289,000 | — | 31 Mar 2021 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.01%
|
9,487
|
$208,000 | — | 31 Mar 2021 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.01%
|
5,486
|
$121,000 | — | 31 Mar 2021 | |
| AMERICAN INTERNATIONAL GROUP, INC. |
13F
|
Company |
0%
|
5,075
|
$112,000 | — | 31 Mar 2021 | |
| NEW YORK STATE COMMON RETIREMENT FUND |
13F
|
Company |
0%
|
3,900
|
$86,000 | — | 31 Mar 2021 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
2,714
|
$60,000 | — | 31 Mar 2021 | |
| UBS Group AG |
13F
|
Company |
0%
|
2,546
|
$56,000 | — | 31 Mar 2021 | |
| STRS OHIO |
13F
|
Company |
0%
|
2,100
|
$46,000 | — | 31 Mar 2021 | |
| Legal & General Group Plc |
13F
|
Company |
0%
|
879
|
$19,000 | — | 31 Mar 2021 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0%
|
794
|
$17,000 | — | 31 Mar 2021 | |
| Ameritas Investment Partners, Inc. |
13F
|
Company |
0%
|
708
|
$16,000 | — | 31 Mar 2021 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
614
|
$14,000 | — | 31 Mar 2021 | |
| CITIGROUP INC |
13F
|
Company |
0%
|
578
|
$13,000 | — | 31 Mar 2021 | |
| BANK OF MONTREAL /CAN/ |
13F
|
Company |
0%
|
292
|
$5,000 | — | 31 Mar 2021 |
Institutional Holders of Terns Pharmaceuticals, Inc. - Common Stock (TERN) as of Q2 2021
As of 30 Jun 2021,
Terns Pharmaceuticals, Inc. - Common Stock (TERN) was held by
36 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
16,621,217 shares.
The largest 10 holders included
ORBIMED ADVISORS LLC, FMR LLC, Vivo Capital, LLC, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), SUVRETTA CAPITAL MANAGEMENT, LLC, MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC, Antara Capital LP, BlackRock Inc., VANGUARD GROUP INC, and Samsara BioCapital, LLC.
This page lists
36
institutional shareholders reporting positions in this security
for the Q2 2021 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2021 vs Q1 2021 Across Filers
Q1 2021 holders
41
Q2 2021 holders
36
Holder diff
-5
| Investor | Q1 2021 Shares | Q2 2021 Shares | Share Diff | Share Chg % | Q1 2021 Value $ | Q2 2021 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.